Leading technology from France.
The Eye Service relies on leading technology made in France: the patented Intense Regulated Pulsed Light (IRPL®) technology. This technology makes it possible to generate perfectly calibrated and homogenous light pulses that help normalize the function of the meibomian glands and thus eliminate dry eyes and consequently further eye pain.
Its high effectiveness was confirmed in clinical trials. The effect lasts only a few days after the first treatment and cumulates with each of the three to four Eye Service treatment sessions. After the second session, complaints are already alleviated significantly.
Trials were conducted with more than 200 representative patients. These trials showed: a marked improvement of complaints perceived by the participants such as dry, burning, red, sticky, itchy eyes, with a satisfaction of 90 % after the first two treatment sessions. This improvement was assessed based on a survey about the complaints prior to and after the treatment and about the improvement achieved with regard to reading or working on a computer screen. The improvement was noticeable already after the first treatment session, would, at first, last several days, and, with every further session, the improvement would last longer and longer.
The trials confirmed that the Eye Service quickly achieves remarkable results in patients suffering from sicca syndrome.